Health Trials

National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype

ConditionsRASopathiesNoonan Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-35
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.

Eligibility criteria

Qualifiers

Clinically diagnosed RASopathy confirmed by molecular testing;

Patients referred to participating centers between 01/01/2001 and 31/12/2022;

Age at enrollment between 2 and 35 years, inclusive;

Obtaining informed consent.

Disqualifiers

None.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

14
Azienda Ospedaliero-Universitaria di Alessandria Alessandria Italy
AOU Policlinico di Bari Bari Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy
AOU Meyer IRCCS Florence Italy

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov